Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cross-Center CDRH Matrix Goes Live After Six Months Of Ground Work

This article was originally published in The Gray Sheet

Executive Summary

Recently appointed leaders of CDRH's new cross-center post-market safety "matrix" organization are officially on the job, beginning July 14, after six months of initial training and testing of the collaborative system

You may also be interested in...



Scrapping The Matrix: CDRH Seeks Alternative Approach To Breaking Silos

Two years after going live, CDRH's "matrix," a structure of network leaders tasked with keeping pre-market and post-market offices communicating, is likely on its way out

Scrapping The Matrix: CDRH Seeks Alternative Approach To Breaking Silos

Two years after going live, CDRH's "matrix," a structure of network leaders tasked with keeping pre-market and post-market offices communicating, is likely on its way out

Inside The “Matrix”: Teaching Device Staff To Triage Safety Signals

FDA's device center is developing a process to help staff spot post-market safety signals and decide when action is necessary

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT026350

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel